R Ballotta
- Topics
- Antimicrobial Resistance in Staphylococcus (4 papers)Synthesis and Characterization of Heterocyclic Compounds (3 papers)Cancer therapeutics and mechanisms (2 papers)
In The Last Decade
R Ballotta
10 papers receiving 274 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 129
- Infectious Diseases 91
- Epidemiology 83
- Organic Chemistry 70
- Pharmacology 66
Countries citing papers authored by R Ballotta
This map shows the geographic impact of R Ballotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Ballotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Ballotta more than expected).
Fields of papers citing papers by R Ballotta
This network shows the impact of papers produced by R Ballotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Ballotta. The network helps show where R Ballotta may publish in the future.
Co-authorship network of co-authors of R Ballotta
This figure shows the co-authorship network connecting the top 25 collaborators of R Ballotta. A scholar is included among the top collaborators of R Ballotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Ballotta. R Ballotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Rifomycin. I. Isolation and properties of rifomycin B and rifomycin complex. | 34 |
| 2 | 3 | |
| 3 | 1-Alkyl-2-nitroimidazol-5-yl derivatives II. N-substituted nitrones. | 2 |
| 4 | 20 | |
| 5 | 20 | |
| 6 | 209 | |
| 7 | Rifamycins. XLII. Rifazine, a new phenazinic derivative of rifamycins. | 3 |
| 8 | 20 | |
| 9 | Rifomycin. V. Rifomycin O, a new antibiotic of the rifomycin family. | 6 |
| 10 | Matamycin, a new antibiotic. II. Isolation and characterization. | 7 |
About R Ballotta
R Ballotta is a scholar working on Infectious Diseases, Molecular Medicine and Organic Chemistry, having authored 10 papers that have together received 324 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Microbiology (8 citations), Molecular Medicine (41 citations) and Drug Discovery (1 citation). Frequent co-authors include P Sensi, N. Maggi, C.R. Pasqualucci, B. CAVALLERI, V. ARIOLI, Giancarlo Lancini, S Fürész, R Pallanza and G.G. Gallo. Their work appears in journals such as Journal of Medicinal Chemistry, Chemotherapy and Journal of Heterocyclic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.